The Thomas R. Beecher, Jr. Innovation Center is pleased to welcome Roswell Park Cancer Institute (RPCI) spin-off companies Tartis Aging, Inc., and OncoTartis, Inc., as its newest tenants. The companies will occupy a combined 5,700-square-foot of wet lab and office space on the fourth floor of the building. Approximately half of this space will be built up as the companies continue to grow in size.
OncoTartis and Tartis Aging are discovery-stage biotechnology companies seeking novel anti-cancer and anti-aging drugs. Their proprietary technologies are licensed from the laboratories of Andrei Gudkov, PhD, from RPCI.
Dr. Gudkov was recruited to Buffalo by RPCI and other local partners in 2007. He moved his research lab and his first commercial company, Cleveland BioLabs, Inc. (CBLI), from the Cleveland Clinic to serve as Senior Vice President of Basic Science and Chair of the Department of Cell Stress Biology at Roswell Park.
The laboratory building at 73 High Street, shared with Cleveland BioLabs, Inc., had been the first home for both corporations. With 15 employees and a growing portfolio, the two companies have outgrown the space available on High Street but wanted to remain on the BNMC.
“We are very hwp-contenty to find space in the Innovation Center, which allows us to expand our research and at the same time continue to be close to our colleagues at CBLI and Roswell Park,” said Aleksandra Kotlyarova, Director of Operations for both companies.
“OncoTartis and Tartis Aging are perfect examples of what we need to see more of here in Buffalo,” said Patrick J. Whalen, Chief Operating Officer of the BNMC, Inc., which owns and operates the Innovation Center. “Dr. Gudkov and Cleveland BioLabs moved to the BNMC several years ago to better collaborate with Roswell Park Cancer Institute, and thanks to the groundbreaking research at Roswell Park, they continue to grow and spin off companies, creating more jobs and economic-development opportunities in Buffalo as they evolve.”
Kari Bonaro (BNMC, Inc.); firstname.lastname@example.org; 716.218.7157